Skip to content

Clinical trials

Completed Lymphoma, Mantle-Cell trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Status: Completed Country / region: China Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20131
20161
20174
20182
20191
20202
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BeiGene2
Bayer1
Beijing InnoCare Pharma Tech Co., Ltd.1
Chinese PLA General Hospital1
Eli Lilly and Company1
Guangzhou Lupeng Pharmaceutical Company LTD.1
InnoCare Pharma Inc.1
Institute of Hematology & Blood Diseases Hospital, China1
Janssen Research & Development, LLC1
Millennium Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell15
Lymphoma, Large B-Cell, Diffuse5
Leukemia, Lymphocytic, Chronic, B-Cell4
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Follicular2
Lymphoma, Non-Hodgkin2
Hematologic Neoplasms1
Leukemia, Lymphoid1
Leukemia, Prolymphocytic1
Lymphoma1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.